In a dramatic pivot that has sent shockwaves through the biotechnology sector, San Diego-based Artiva Biotherapeutics announced this week that...
In a monumental development that reshapes the landscape of the global life-sciences sector, Swedish private equity giant EQT has reached...
Hantaviruses have long been recognized as formidable threats to human health. While many hantaviruses are transmitted primarily through contact with...
Executive Summary: A Paradigm Shift in Oncology In a landmark development for precision medicine, an international coalition of scientists has...
In a groundbreaking convergence of bioengineering, electrochemistry, and digital health, an international research team has unveiled a revolutionary device that...
After four years of post-pandemic stagnation, the biotechnology sector has finally emerged from its winter. As of late 2026, the...
For decades, the medical community and the general public have operated under a pervasive assumption: once a woman reaches menopause,...
In an industry where the sheer volume of biological data threatens to outpace the tools available to interpret it, Illumina...
In the decades-long battle against Alzheimer’s disease, the scientific community has largely fixated on a single, stubborn adversary: the extracellular...
In a development that has sent shockwaves through the biotech sector, Caribou Biosciences (Nasdaq: CRBU)—the Berkeley-based genome-editing powerhouse co-founded by...
Broadcast Date: November 4, 2025 The pharmaceutical landscape is undergoing a transformation that many industry observers describe as the most...
On a quiet Thursday in August 2026, a scene unfolded at Mirabella at ASU that perfectly encapsulated the intersection of...
